Chicago has been a prime location for many entrepreneurs to settle into, including Eric Lefkofsky. Eric is a highly accomplished entrepreneur and businessman that resides in the Chicago area with a major focus on the technology industry. One of Eric’s latest approaches to the technology industry is through his company, Tempus. This new company of Eric’s was started up just a couple years ago and is focused on collecting large amounts of data relating to the healthcare industry, most especially cancer research and treatment information. It is Eric’s hope that Tempus will be able to aid medical practitioners with their patient’s treatments when it comes to cancer. Tempus recently developed a mobile app to accompany the growth of the company known as Tempus Labs.
For over a year now, Tempus Labs has undergone extensive testing by researchers and a handful of board-certified physicians from across the country. The primary focus for the Tempus Labs app is to provide the data collected by Tempus in a hands-on device in a very fast way. By making this data available on virtually any phone for licensed physicians, Tempus will start building even more traction and start improving procedures performed by medical practitioners. In order to actually get their hands on the app, physicians will need to contact Tempus and order the Tempus CLIA. When it comes to the field of cancer research, data is very patient-specific, which makes it difficult to provide good treatment for each individual. Eric Lefkofksy believes Tempus will help bridge that gap in a few short years.
After a successful round of funding that pulled in more than 100 million dollars, Eric Lefkofksy financially announced the arrival of Tempus Labs, which has increased the interest in Tempus by the public by a huge amount. Data access is widely varied from one medical organization to another, which makes the research at Tempus and data collection highly valuable.